Raelipskie Partnership’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Raelipskie Partnership's RGEN Position: Q1 2026 in Review
Raelipskie Partnership held its Repligen (RGEN) position steady in Q1 2026 at 25 shares worth $2.95K. The position accounts for ﹤0.01% of the portfolio, ranked #103.
Raelipskie Partnership first reported a position in RGEN in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.6K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Raelipskie Partnership held 25 shares of Repligen worth $2.95K as of Q1 2026.
- Raelipskie Partnership left its Repligen share count unchanged in Q1 2026.
- Repligen made up ﹤0.01% of Raelipskie Partnership's portfolio in Q1 2026, its #103 holding.
- Raelipskie Partnership first reported a position in Repligen in Q4 2023 and has held it in 10 quarters since.
- Raelipskie Partnership's Repligen position peaked at $4.6K in Q1 2024.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Raelipskie Partnership's 13F filing for Q1 2026, filed 29 Apr 2026.